Vertex Pharmaceuticals (VRTX) EBT Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 32.79% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 47.54% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -49.71% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 12.01% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 20.92% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -1.05% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67% |
| 10 | Revolution Medicines | 31.20 Bn | 31.20 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.01% |
| Dec 31, 2025 | 7.32% |
| Sep 30, 2025 | 3.35% |
| Jun 30, 2025 | 7.79% |
| Mar 31, 2025 | -8.54% |
| Dec 31, 2024 | 9.28% |
| Sep 30, 2024 | 4.17% |
| Jun 30, 2024 | -324.92% |
| Mar 31, 2024 | 15.93% |
| Dec 31, 2023 | 8.90% |
| Sep 30, 2023 | 16.50% |
| Jun 30, 2023 | 12.09% |
| Mar 31, 2023 | 10.68% |
| Dec 31, 2022 | 16.73% |
| Sep 30, 2022 | 155.34% |
| Jun 30, 2022 | 46.30% |
| Mar 31, 2022 | 43.94% |
| Dec 31, 2021 | 199.26% |
| Sep 30, 2021 | 99.43% |
| Jun 30, 2021 | -30.14% |
| Mar 31, 2021 | 56.38% |
| Dec 31, 2020 | 99.19% |
| Sep 30, 2020 | 55.88% |
| Jun 30, 2020 | 185.33% |
| Mar 31, 2020 | 37.39% |
| Dec 31, 2019 | 221.84% |
| Sep 30, 2019 | 56.19% |
| Jun 30, 2019 | 172.13% |
| Mar 31, 2019 | 131.81% |
| Dec 31, 2018 | 34.39% |
| Sep 30, 2018 | 51.48% |
| Jun 30, 2018 | 46.35% |
| Mar 31, 2018 | 45.52% |
| Dec 31, 2017 | 38.03% |
| Sep 30, 2017 | -35.80% |
| Jun 30, 2017 | 30.53% |
| Mar 31, 2017 | 45.75% |
| Dec 31, 2016 | 44.83% |
| Sep 30, 2016 | 31.02% |
| Jun 30, 2016 | 30.55% |
| Mar 31, 2016 | 58.67% |
| Dec 31, 2015 | 1.99% |
| Sep 30, 2015 | -162.52% |
| Jun 30, 2015 | -136.63% |
| Mar 31, 2015 | -62.07% |
| Dec 31, 2014 | -41.73% |
| Sep 30, 2014 | -41.45% |
| Mar 31, 2014 | -9.52% |
| Dec 31, 2013 | 52.31% |
| Sep 30, 2013 | 17.13% |
| Jun 30, 2013 | 35.45% |
| Mar 31, 2013 | -38.36% |
| Dec 31, 2012 | 18.82% |
| Sep 30, 2012 | 67.55% |
| Jun 30, 2012 | 55.09% |
| Mar 31, 2012 | 36.45% |